The invention relates to compounds of formula (I):
as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
本发明涉及式(I)的化合物,如本文所述,包括这些化合物的药物制剂,以及在治疗由M
DM2和/或M
DM4活性介导的疾病或疾病中使用这些化合物的用途和使用方法,以及包含这些化合物的组合物。